Skip to main content
SNGX logo

Soligenix, Inc.

SNGXNASDAQHealthcareBiotechnology

$0.35Today:- (-)1Y −78.48%

As of Oct 16, 2026 close

Market cap
$5.66M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.28$1.76
Volume (live)
-
Avg. volume (3M)
206.14K

Soligenix (SNGX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), Soligenix used $10.27M of cash in operating activities and spent $5.88K on capital expenditures. That left free cash flow of −$10.27M.

Soligenix Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Soligenix, Inc. (SNGX) - Annual data in millions USD
BreakdownFY 2025FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-11.08-11.08-8.27-6.14-13.80-12.55-17.69-9.36-8.90-7.15
Depreciation & Amortization0.000.000.010.010.020.030.180.050.040.07
Deferred Income Tax0.00-0.000.000.00-0.420.000.000.000.00
Stock Based Compensation0.590.590.350.490.550.360.470.380.380.49
Change in Working Capital0.030.03-0.35-3.440.430.650.511.141.230.07
Change in Accounts Receivable0.00-0.17-0.060.020.060.820.18-0.280.28
Change in Inventory0.00-0.000.000.00-1.131.16-1.970.000.00
Change in Accounts Payable-0.02-0.02-0.49-2.690.401.13-1.161.971.020.38
Change in Other Working Capital0.050.19-0.11-0.61-0.030.590.850.951.50-0.21
Other Operating Activities0.190.19-0.140.470.150.195.250.280.000.01
Net Cash from Operating Activities-10.27-10.27-8.40-8.60-12.65-11.74-11.45-7.51-7.24-6.51
Investing Activities
Capital Expenditures-0.01-0.010.000.00-0.01-0.01-0.01-0.030.00-0.03
Acquisitions0.00-0.000.000.000.000.000.010.000.00
Other Investing Activities0.00-0.000.000.000.000.000.010.000.00
Net Cash from Investing Activities-0.01-0.010.000.00-0.01-0.01-0.01-0.020.00-0.03
Financing Activities
Debt Repayment-1.37-1.37-1.37-7.000.00-0.01-0.01-0.010.000.00
Common Stock Issued12.4712.1610.2611.590.0819.7115.064.148.686.25
Other Financing Activities-0.71-0.71-1.13-0.930.00-0.64-0.80-0.13-0.25-0.67
Net Cash from Financing Activities10.3910.397.763.660.0819.0624.684.018.425.57
Summary
Effect of Forex Changes on Cash0.00-0.010.03-0.100.060.04-0.030.000.00
Net Change in Cash0.120.12-0.63-4.91-12.687.3713.26-3.561.17-0.96
Cash at Beginning of Period7.827.828.4513.3626.0418.685.428.987.818.77
Cash at End of Period7.947.947.828.4513.3626.0418.685.428.987.81
Free Cash Flow-10.27-10.27-8.40-8.60-12.66-11.75-11.46-7.54-7.25-6.54
Supplemental Disclosures
Interest Paid--0.230.550.860.670.03---
Income Taxes Paid--0.040.020.020.010.00---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Soligenix Cash Flow

What is Soligenix's free cash flow?

Soligenix had negative free cash flow of $10.27M in fiscal 2025 (fiscal year ended Mar 31, 2026), operating cash flow of −$10.27M minus $5.88K of capital expenditures.

How much does Soligenix spend on capital expenditures?

Soligenix spent $5.88K on capital expenditures in fiscal 2025.

Does Soligenix pay dividends or buy back shares?

Soligenix's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition